Resurrection Medical Center
7447 West Talcott Avenue
Chicago, IL 60631
Resurrection Medical Center participates in clinical trials, which are studies that evaluate the effectiveness of new drugs, diagnostic tests and treatment strategies. Hospital oncologists bring cancer patients advanced medicine by offering clinical trials covering a wide range of areas such as breast, colon, lung, kidney and prostate cancer as well as others. These trials are conducted by recognized research organizations affiliated with the National Cancer Institute.
The development of more effective cancer treatments requires that new and innovative therapies be evaluated with cancer patients. Each clinical trial is designed to find new or better ways to treat cancer patients. In oncology, clinical trials are especially important because, in the absence of high cure rates, nearly all therapeutic approaches are the result of clinical trials.
Clinical trials offer access to new treatments not yet available to the general population. Patients are monitored closely by physicians at the forefront of cancer research and may be the first to benefit from new treatments. In addition, research patients’ safety is monitored by both the study’s sponsor and RMC’s Institutional Review Board, a group of people who review research to protect patient rights and welfare.
If you would like more information about clinical trials offered at Resurrection Medical Center, please call the Clinical Research Program at 773-594-7821.